Related Experiment Video
Updated: Jun 9, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotic Supplementation in the Neonatal Age Group and the Risk of Hospitalisation in the First Two Years: A Data
Ravisha Srinivasjois1,2,3, Amanuel Gebremedhin1,4, Desiree Silva2,3
1Curtin School of Population Health, Curtin University, Perth, WA 6102, Australia.
Insights
Probiotic supplementation for preterm infants reduced hospitalizations by 8% within two years. This study highlights the long-term benefits of probiotics for very premature babies after neonatal care.
Area of Science:
- Neonatal Medicine
- Pediatric Gastroenterology
- Infectious Disease Prevention
Background:
- Probiotic supplementation is common for preterm neonates globally.
- Previous research has not detailed the long-term impact of neonatal probiotics on infant hospitalization risks.
Purpose of the Study:
- To investigate the effect of probiotic supplementation in preterm neonates on subsequent hospitalization rates.
- To analyze hospitalization risks for respiratory and gastrointestinal infections up to two years post-discharge.
Main Methods:
- Retrospective cohort study of preterm infants born before 32 weeks gestation in Western Australia.
- Comparison of hospitalization data before (Epoch 1) and after (Epoch 2) the implementation of probiotic supplementation.
- Subgroup analysis for infants born before 28 weeks gestation.
Main Results:
- An 8% reduction in hospitalizations up to two years post-birth was observed after probiotic implementation (adjusted IRR 0.92; 95% CI 0.87-0.98).
- Adjustments were made for gestational age, smoking, socioeconomic status, and maternal age.
- Hospitalization rates for extremely preterm infants (<28 weeks) remained comparable between the two epochs.
Conclusions:
- Neonatal probiotic exposure is associated with a decreased risk of hospitalization in the first two years after neonatal unit discharge.
- Probiotics may offer a protective effect against common infant infections requiring hospitalization.
- Further research could explore specific probiotic strains and optimal timing for administration.
Background:
Probiotic supplementation in preterm neonates is standard practice in many centres across the globe. The impact of probiotic supplementation in the neonatal age group on the risk of hospitalisation in infancy has not been reported previously.
Methods:
Infants born < 32 + 6 weeks of gestation in Western Australia were eligible for inclusion. We conducted a retrospective cohort study comparing data from before probiotic supplementation (Epoch 1: 1 December 2008-30 November 2010, n = 1238) versus after (Epoch 2: 1 June 2012-30 May 2014, n = 1422) on the risks of respiratory- and gastrointestinal infection-related hospitalisation. A subgroup analysis of infants born < 28 weeks of gestation was analysed separately for similar outcomes.
Results:
Compared to Epoch 1, an 8% reduction in incidence of hospitalisation up to 2 years after birth was observed in Epoch 2 (adjusted incidence rate ratio (IRR) of 0.92; 95% confidence interval (CI); 0.87-0.98), adjusted for gestational age, smoking, socioeconomic status, and maternal age. The rate of hospitalisation for infants born < 28 weeks of gestation was comparable in epochs 1 and 2.
Conclusion:
Infants exposed to probiotic supplementation in the neonatal period experience a reduced risk of hospitalisation in the first two years after discharge from the neonatal unit.
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Probiotics
Introduction to the Human Microbiota
Development of Human Microbiota
Development of the Oral Microbiota
Microbiota Modulation by Antibiotics

